| Expanding global access to radiotherapy R Atun, DA Jaffray, MB Barton, F Bray, M Baumann, B Vikram, TP Hanna, ... The lancet oncology 16 (10), 1153-1186, 2015 | 1136 | 2015 |
| Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β= 1.4 (0.9–2.2) Gy R Miralbell, SA Roberts, E Zubizarreta, JH Hendry International Journal of Radiation Oncology* Biology* Physics 82 (1), e17-e24, 2012 | 584 | 2012 |
| Need for radiotherapy in low and middle income countries–the silent crisis continues EH Zubizarreta, E Fidarova, B Healy, E Rosenblatt Clinical oncology 27 (2), 107-114, 2015 | 362 | 2015 |
| Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis M Abdel-Wahab, JM Bourque, Y Pynda, J Iżewska, D Van der Merwe, ... The lancet oncology 14 (4), e168-e175, 2013 | 355 | 2013 |
| Global access to radiotherapy services: have we made progress during the past decade? ML Yap, E Zubizarreta, F Bray, J Ferlay, M Barton Journal of global oncology 2 (4), 207-215, 2016 | 147 | 2016 |
| Breast conservation treatment of early stage breast cancer: patterns of failure F Leborgne, JH Leborgne, B Ortega, R Doldan, E Zubizarreta International Journal of Radiation Oncology* Biology* Physics 31 (4), 765-775, 1995 | 136 | 1995 |
| Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial F Leborgne, JH Leborgne, R Doldán, E Zubizarreta, B Ortega, ... International Journal of Radiation Oncology* Biology* Physics 37 (2), 343-350, 1997 | 115 | 1997 |
| Accuracy requirements and uncertainties in radiotherapy: a report of the International Atomic Energy Agency D van der Merwe, J Van Dyk, B Healy, E Zubizarreta, J Izewska, ... Acta oncologica 56 (1), 1-6, 2017 | 111 | 2017 |
| Global radiotherapy: current status and future directions—white paper M Abdel-Wahab, SS Gondhowiardjo, AA Rosa, Y Lievens, N El-Haj, ... JCO global oncology 7, 827-842, 2021 | 96 | 2021 |
| Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines R Mir, SM Kelly, Y Xiao, A Moore, CH Clark, E Clementel, C Corning, ... Radiotherapy and Oncology 150, 30-39, 2020 | 92 | 2020 |
| Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA) EH Zubizarreta, A Poitevin, CV Levin Radiotherapy and oncology 73 (1), 97-100, 2004 | 90 | 2004 |
| Radiotherapy resources in Africa: an International Atomic Energy Agency update and analysis of projected needs SNC Elmore, A Polo, JM Bourque, Y Pynda, D van der Merwe, S Grover, ... The Lancet Oncology 22 (9), e391-e399, 2021 | 84 | 2021 |
| Radiotherapy in cancer care: facing the global challenge E Rosenblatt, E Zubizarreta International Atomic Energy Agency, 2017 | 82 | 2017 |
| Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis J Van Dyk, E Zubizarreta, Y Lievens Radiotherapy and Oncology 125 (2), 178-185, 2017 | 74 | 2017 |
| Radiation therapy quality assurance in clinical trials–Global Harmonisation Group C Melidis, WR Bosch, J Izewska, E Fidarova, E Zubizarreta, S Ishikura, ... Radiotherapy and oncology: journal of the European Society for Therapeutic …, 2014 | 74 | 2014 |
| Improving quality and access to radiation therapy—an IAEA perspective M Abdel-Wahab, E Zubizarreta, A Polo, A Meghzifene Seminars in radiation oncology 27 (2), 109-117, 2017 | 72 | 2017 |
| Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey D Rodin, B Tawk, O Mohamad, S Grover, FY Moraes, ML Yap, ... Radiotherapy and oncology 157, 32-39, 2021 | 70 | 2021 |
| Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial JH Leborgne, F Leborgne, E Zubizarreta, B Ortega, J Mezzera Radiotherapy and oncology 47 (2), 145-148, 1998 | 63 | 1998 |
| Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and … D Rodin, EA Burger, R Atun, M Barton, M Gospodarowicz, S Grover, ... The lancet oncology 20 (7), 915-923, 2019 | 62 | 2019 |
| Global harmonization of quality assurance naming conventions in radiation therapy clinical trials C Melidis, WR Bosch, J Izewska, E Fidarova, E Zubizarreta, K Ulin, ... International Journal of Radiation Oncology* Biology* Physics 90 (5), 1242-1249, 2014 | 59 | 2014 |
Danielle RodinPrincess Margaret Cancer CentreAdresă de e-mail confirmată pe rmp.uhn.ca
